#Surgical Site Infection Control Market Share

[blog-site-for-market-research]

Assessing the Size and Scope of Surgical Site Infection Control Market

Market Overview –

Over the projection period of 2022–2030, the surgical site infection control market is projected to grow at a 5.80% CAGR to reach USD 4969.21 million by 2030.

The Post-Surgical Infection Prevention market is gaining momentum as healthcare facilities prioritize patient safety. Surgical site infections pose a significant risk, driving demand for effective control measures. Manufacturers offer a range of products, including antimicrobial dressings and disinfectants, to minimize infection rates. With increasing emphasis on healthcare-associated infection prevention, the market for post surgical infection prevention is poised for steady growth.

The Surgical Site Infection Control Market addresses the prevention and management of infections that occur at surgical sites. Surgical site infections (SSIs) are a significant concern in healthcare settings, leading to prolonged hospital stays, increased healthcare costs, and patient morbidity. Therefore, the market focuses on products and strategies aimed at reducing the incidence of SSIs.

Key drivers of the market include the rising number of surgical procedures globally, increasing awareness about the importance of infection control measures, and stringent regulations mandating infection prevention protocols in healthcare facilities. Additionally, advancements in technology have led to the development of innovative products and techniques for surgical site infection control, further fueling market growth.

The market offers a wide range of products and solutions, including antimicrobial sutures, disinfectants, surgical drapes, and wound care products. These products aim to minimize the risk of bacterial contamination during surgical procedures and promote optimal wound healing.

Furthermore, healthcare facilities are increasingly adopting comprehensive infection control protocols, including preoperative screening, antibiotic prophylaxis, and postoperative surveillance, to mitigate the risk of SSIs. Such measures contribute to the expansion of the surgical site infection control market.

Despite the market's growth potential, challenges such as antibiotic resistance, healthcare-associated infections, and resource constraints in healthcare settings may hinder market growth. Nonetheless, the growing emphasis on patient safety and quality of care is expected to sustain demand for surgical site infection control products and solutions in the foreseeable future.

Segmentation –

The global surgical site infection control market is segmented based on product, procedure, type of infection, end user, and region.

On the basis of product, the market is segmented into manual reprocesses solution, disinfectants, surgical scrubs, surgical drapes, skin preparation solution, medical nonwovens, surgical gloves, and others. The disinfectants are segmented into hand disinfectants and skin disinfectants. On the basis of procedure, the market is segmented into cataract surgery, caesarean section, dental restoration, gastric bypass, and others.  On the type of infection, the market is segmented into superficial incisional SSI, deep incisional SSI organ or space SSI. On the basis of end user, the market is segmented into hospitals and ambulatory surgical centres.

Regional Analysis –

The Surgical Site Infection Control Market demonstrates distinct regional dynamics shaped by factors such as healthcare infrastructure, infection control practices, and regulatory standards. North America leads the market, driven by stringent regulations, advanced healthcare facilities, and a high focus on patient safety. The region witnesses substantial investments in infection prevention measures, including the adoption of advanced technologies and stringent protocols, contributing to a significant market share.

Similarly, Europe portrays a lucrative market landscape, characterized by robust healthcare systems, stringent infection control guidelines, and a proactive approach towards surgical safety. In Asia Pacific, the market is experiencing rapid growth due to increasing surgical procedures, expanding healthcare infrastructure, and rising awareness about the importance of infection control measures. Countries like China and India are driving market expansion with their growing healthcare expenditure and emphasis on improving surgical outcomes. Latin America and the Middle East & Africa regions present opportunities for market growth, propelled by improving healthcare infrastructure and rising investments in infection control measures. However, challenges such as limited access to healthcare resources and variability in healthcare quality may impact market penetration in these regions. Overall, the Surgical Site Infection Control Market displays promising growth prospects across diverse regions, driven by the universal need for effective infection control solutions in surgical settings.

Key Players –

Pharmaceutical Analytical Testing Outsourcing Key players include 3M, Becton Dickinson and Company, Belimed AG, bioMerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark Corporation, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp, American Polyfilm Inc., and others.

Related Reports –

Oral Cancer Diagnostics

Automatic Pill Dispenser

Lancet

Medical Oxygen Concentrators

For more information visit at MarketResearchFuture

[farmacuticals]

Analyzing Growth Trends in the Wound Irrigation System Market: Opportunities and Challenges

A Wound Irrigation System is a medical device designed to cleanse wounds efficiently, promoting faster healing and reducing the risk of infection. This system uses a steady stream of fluid, often saline, to flush debris, bacteria, and foreign material from a wound site. Unlike traditional wound cleaning methods, a Wound Irrigation System can reach deeper and harder-to-clean areas, making it highly effective for various types of wounds, including surgical, traumatic, and chronic wounds. The device can be handheld or automated, depending on the clinical need and the environment in which it's used, such as hospitals, clinics, or even for home care.

The Wound Irrigation System Market Size was projected to reach 2.15 billion USD in 2022, according to MRFR analysis. It is anticipated that the market for wound irrigation systems would increase from 2.26 billion USD in 2023 to 3.56 billion USD in 2032. Over the course of the forecast period (2024–2032), the wound irrigation system market is anticipated to develop at a CAGR of approximately 5.16%.

Wound Irrigation System Size

The global Wound Irrigation System market size is expanding significantly, driven by the rising prevalence of chronic wounds, such as diabetic ulcers, and the increasing awareness of advanced wound care solutions. This market growth reflects a higher demand for infection prevention, which is essential to reduce hospital stays and medical costs. The size of a Wound Irrigation System typically varies depending on the intended use. Smaller, portable systems are often used in home care settings, while larger, more robust systems are prevalent in clinical environments. This variety in size allows for flexibility in application, serving both small, easily managed wounds and larger or more complex cases requiring intensive irrigation.

Wound Irrigation System Share

The Wound Irrigation System market share is distributed among several key players, with hospitals and clinics occupying a significant portion due to their higher need for advanced wound care technologies. Additionally, there is an increasing adoption in outpatient settings and home healthcare. Geographic regions such as North America and Europe hold a substantial market share, attributed to the high prevalence of chronic conditions requiring wound management and advanced healthcare infrastructures. However, emerging markets in Asia-Pacific are expected to gain momentum, driven by an increasing healthcare budget, greater access to medical facilities, and growing awareness regarding wound care.

Wound Irrigation System Analysis

Analyzing the Wound Irrigation System market highlights several driving factors, including the rise in surgical procedures, the aging population, and increased incidences of chronic illnesses like diabetes. These factors contribute to a higher need for effective wound management solutions. The analysis also indicates that technological advancements, such as portable and battery-operated devices, are adding value to the market, making wound irrigation more accessible and practical in various healthcare settings. Furthermore, as healthcare policies increasingly focus on infection prevention and patient outcomes, Wound Irrigation System adoption is expected to grow steadily in the coming years.

Wound Irrigation System Trends

Several key trends are shaping the Wound Irrigation System market. One trend is the shift towards portable, easy-to-use devices that allow patients to manage their wound care at home. Another trend is the integration of antimicrobial solutions within irrigation systems to improve infection control. Additionally, eco-friendly and disposable products are becoming more popular as healthcare facilities focus on sustainability. Digital advancements, such as devices with built-in pressure and flow sensors, are also emerging, providing better control over wound cleansing and enhancing patient outcomes.

Reasons to Buy the Report

Comprehensive Market Insight: The report offers an in-depth overview of the Wound Irrigation System market, including historical data, current trends, and future projections.

Regional Analysis: Gain knowledge about regional market shares, helping to identify potential growth areas and expansion opportunities.

Competitive Landscape: Understand the key players, their market strategies, recent developments, and how they impact the Wound Irrigation System industry.

Trends and Forecasts: The report highlights significant trends, allowing businesses to anticipate market direction and make informed decisions.

Technological Advancements: Stay updated on the latest technological innovations in Wound Irrigation Systems that improve efficiency and patient care.

Recent Developments

Recent developments in Wound Irrigation Systems include the introduction of automated irrigation devices, which offer consistent fluid pressure for effective wound cleansing. Some systems now feature antimicrobial agents integrated within irrigation fluids, enhancing infection control and promoting faster healing. Additionally, several companies have introduced battery-powered portable devices for home healthcare. Digital advancements, like smart systems that can adjust fluid pressure based on wound depth and type, are also emerging. These innovations are expected to drive the market forward, improving the efficiency and accessibility of wound care.

relate reports :

pharmaceutical solvent market

plastic surgery instrument market

ai in pathology market

Top of Form

Bottom of Form

[industrynewsupdates]

Key Drivers Behind the Growth of the Infection Control Market

The global infection control market was valued at USD 214.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This growth is primarily driven by the increasing number of surgical and clinical procedures that require intensive infection prevention measures. The growing preference for infection control products and practices can largely be attributed to the positive clinical outcomes associated with their use in reducing infections. The COVID-19 pandemic further contributed to this market expansion, as the demand for sterilization, disinfection, and infection control solutions surged across hospitals, clinics, and other healthcare facilities, as well as pharmaceutical and medical device companies.

According to statistics from the World Health Organization (WHO), Acute Respiratory Diseases (ARDs) are a leading cause of mortality worldwide, with approximately 4 million deaths occurring each year due to ARDs. This data highlights the pressing need for effective infection control measures globally. Hospital-acquired infections (HAIs) represent another significant area of concern, as they are responsible for a substantial number of patient illnesses and deaths. Common types of HAIs include pneumonia, bloodstream infections, urinary tract infections (UTIs), surgical site infections (SSIs), and Methicillin-resistant Staphylococcus aureus (MRSA). HAIs, such as catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstream infections, pose major challenges to patient recovery and significantly impact mortality rates worldwide. The high prevalence of HAIs underscores the critical demand for infection control solutions that can improve patient outcomes and reduce the incidence of infections.

Gather more insights about the market drivers, restrains and growth of the Infection Control Market

End-use Insights

The global infection control market is segmented based on end-use into medical device companies, hospitals, pharmaceutical companies, clinical laboratories, and others. The hospital segment accounted for the largest share of the market, holding around 40% of the total revenue in 2022. This segment is expected to continue growing at the fastest rate, with a CAGR of 7.4% from 2023 to 2030. The large market share of hospitals is primarily due to the high risk of infection in hospital settings, where blood-borne, respiratory, and other pathogens can easily spread. Hospital-acquired infections (HAIs) represent a major challenge within these environments, contributing to the need for stringent infection control measures. Research published by the National Center for Biotechnology Information (NCBI) estimates that 40% to 60% of hospital infections are surgical site infections (SSIs), further emphasizing the importance of infection control in surgical settings.

Hospitals are particularly vulnerable to the spread of drug-resistant pathogens, blood-borne pathogens, and other infectious agents in areas such as operating rooms, patient care units, and intensive care units (ICUs). One specific concern is the frequent use of urinary catheters, which are associated with a high risk of urinary tract infections (UTIs), particularly catheter-associated urinary tract infections (CA-UTIs). According to data from the NCBI, UTIs account for approximately 25% of all bacterial infections. Additionally, the National Nosocomial Infection Surveillance (NNIS) system report reveals that catheter-associated bacteriuria and catheterization-related infections are among the most common HAIs in the U.S., contributing to 40% of all HAIs annually.

These alarming statistics highlight the pressing need for infection control measures in hospital settings, especially concerning the prevention of catheter-associated infections and other types of hospital-acquired infections. The high prevalence of these infections, combined with the increasing adoption of advanced infection control technologies, is expected to drive significant market growth in the hospital sector.

The increasing adoption of effective infection control practices in hospitals is therefore expected to boost market demand for products such as sterilization equipment, disinfection solutions, personal protective equipment (PPE), and infection monitoring systems. As the healthcare sector continues to focus on improving patient safety and reducing the burden of HAIs, hospitals will play a crucial role in the overall growth of the infection control market.

Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.

[omkarpatel]

Surgical Sinks Market is estimated to Witness High Growth Owing to Increasing Number of Hospitals and Healthcare Facilities

Surgical sinks are specialized sinks used in operating rooms, surgical centers, clinics, and other medical settings for handwashing and disposing of waste. They come equipped with features like integrated soap dispensers and drying stations to maintain sterility.

Market Dynamics: The surgical sinks market is expected to grow significantly during the forecast period owing to the increasing number of hospitals and healthcare facilities globally. According to the American Hospital Association, the number of registered hospitals in the United States grew from 5,021 in 2014 to 5,198 in 2020. Furthermore, the focus on infection control and prevention in healthcare settings is also expected to promote the adoption of specialized sinks like surgical sinks that reduce the risk of contamination.Surgical sinks often have ergonomic designs, antimicrobial surfaces, elbow- or foot-operated taps, and other features that reduce contact with surfaces and increase hygiene compliance among medical professionals. This fuels their preference over conventional sinks.

Major Driver: Increasing Prevalence of Chronic Diseases Requiring Surgical Procedures

The prevalence of chronic diseases such as cardiovascular diseases, cancer, diabetes and various other lifestyle diseases are on the rise globally. Many of these chronic conditions often require various types of surgical procedures such as bypass surgeries, tumor/cancer removal surgeries, amputations etc. This increasing prevalence of chronic diseases directly translates to rising surgical volumes worldwide. As surgical sinks play a crucial role in hygienic preparation and washing of surgical instruments and hands, their demand is strongly correlated with surgical volumes. With surgical procedures projected to increase substantially in the coming years due to growing chronic disease burden, the demand for surgical sinks in operating rooms and other clinical areas is expected to follow a similar upward trend.

Major Driver: Growing Emphasis on Infection Control in Healthcare Settings Healthcare associated infections or HAIs have emerged as a major concern globally with millions affected every year. Surgical site infections are among the most common and costly HAIs. Due to the strict guidelines and regulations around infection control and prevention, hospitals and surgical centers are investing heavily in equipment and tools that can help reduce the risk of surgical infections. Surgical sinks equipped with advanced features like hands-free operation, antimicrobial surfaces etc. have proven effective in improving hygiene and lowering infection rates in surgical environments. The growing focus of regulatory agencies as well as care providers on minimizing healthcare associated infections is anticipated to drive greater adoption of technologically advanced surgical sinks in the upcoming years.

Major Restrain: High Cost of Advanced Surgical Sinks While standard basic surgical sinks fulfill the basic requirements, advanced sinks equipped with high-end features often come at a significantly higher capital cost. Features like touchless operation, automated and customized water controls, antimicrobial surfaces etc. that enhance utility and efficacy usually translate to a higher price tag for surgical sinks. Limited healthcare budgets, especially in price-sensitive developing markets, can restrict the widespread adoption of premium-priced advanced surgical sinks. Nonetheless, the cost factor is gradually diminishing as competition increases manufacturing efficiencies and demand grows over time.

Major Opportunity: Emerging Markets in Asia Pacific and Latin America The surgical sinks market in developed regions like North America and Western Europe is quite mature with established players holding majority market share. However, emerging economies in Asia Pacific and Latin America present lucrative growth opportunities. factors such as rapidly growing private healthcare sectors, rising medical tourism, increasing patient affordability and awareness around quality healthcare are fueling the demand for modern hospital infrastructure and equipment in these regions. Nations like India, China, Brazil, Mexico etc. offer plenty of untapped potential for surgical sink manufacturers. With their cost-competitiveness, new players can gain market access by tailoring their product portfolio as per the requirements and budgets of healthcare facilities in developing Asian and Latin American countries.

Major Trend: Growing Adoption of Touchless and Sensor-Based Sinks Design innovation is a key trend in the surgical sinks industry with players coming up with newer variants focused on enhanced safety, hygiene and utility. There is growing preference among hospitals and ambulatory surgical centers for touchless and sensor-activated surgical sinks that minimize hand contact. These sinks deploy infrared sensors or foot pedals for contactless operation thus eliminating manual touch points that can spread germs or virus. Their self-closing taps and automatic water controls further improve hygiene. As healthcare stakeholders pay greater attention to infection risks amid COVID-19, the demand for touchless sinks featuring advanced technology is projected to increase significantly in the surgical sinks market going forward.

[pavanpj]

"Future-proofing Healthcare: Medical Device Coating Market Size, Share, and Evolutionary Trends"

 The medical device coating market has witnessed significant growth and innovation in recent years, driven by the increasing demand for advanced medical devices and the need for improved functionality, biocompatibility, and durability. Coatings play a vital role in enhancing the performance and safety of medical devices, and the market is expected to continue its upward trajectory. In this article, we will provide an overview of the medical device coating market, along with current industry news and trends.

The global medical device coating market size is likely to be valued at US$ 1.2 Bn by 2021-end, with an anticipated CAGR of 7.2% across the 2021-2031 assessment period, with sales of hydrophilic coatings expected to be maximum at US$ 2 Bn. Overall, the market is slated to reach US$ 2.4 Bn by 2031.

Download a Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5421 

Market Overview:

The global medical device coating market has been steadily expanding, and it is expected to reach new heights in the coming years. Coatings are applied to a wide range of medical devices, including implants, catheters, surgical instruments, and diagnostic equipment, to improve their performance, biocompatibility, and longevity. These coatings can offer benefits such as reduced friction, anti-microbial properties, and enhanced corrosion resistance. The market is segmented based on the type of coating material, which includes polymers, metals, ceramics, and hydrophilic coatings, among others.

One of the key drivers for the growth of the medical device coating market is the increasing aging population worldwide. As the elderly population continues to grow, there is a higher demand for medical devices and procedures, which, in turn, drives the need for advanced coatings to ensure safety and effectiveness. Additionally, technological advancements in the field of medical device coatings have enabled the development of innovative solutions that address various medical challenges.

Competitive Landscape

In the coming decade, manufacturers in the coatings for medical devices market will primarily focus on strategic acquisitions, collaborations, and product launches.

In September 2021, Hydromer Inc. announced that its new facility in North Carolina is fully operational, with extensive new capabilities. Being a global super-specialty coatings for medical and industrial applications manufacturer, the facility will produce coatings which can be heat or UV cured, in solvent and water based versions

Likewise, in the same month, Biocoat Inc. announced the expansion of its on-site ISO-certified, full-service contract coating service unit to include the ability to cure via UV light and plasma treat interventional medical devices. It has additionally announced the introduction of plasma treatment services for difficult to coat substances

 Key Companies Profiled

AdvanSource Biomaterials Corporation

AeonClad Coatings LLC

Allvivo Vascular Inc.

Armology of Connecticut Inc.

AST Products Inc.

Biocoat Inc.

Carmeda AB

Covalon Technologies Ltd.

Hemoteq AG

Hydromer Inc.

Materion Corp.

Royal DSM N.V (DSM Corporation)

Industry News and Trends:

Nano-Coatings for Enhanced Performance: Nanotechnology is playing a crucial role in the development of advanced medical device coatings. Nanocoatings offer superior properties, such as improved adhesion, reduced wear, and better biocompatibility. These coatings are used to enhance the performance of medical devices like stents and orthopedic implants. The market is witnessing increased investment in research and development for nano-coating technologies.

Anti-Microbial Coatings: In light of the recent emphasis on infection control, anti-microbial coatings have gained significant traction. These coatings are designed to inhibit the growth of bacteria and other pathogens on medical devices, reducing the risk of healthcare-associated infections. Hospitals and healthcare facilities are increasingly adopting anti-microbial coated devices to ensure patient safety.

Hydrophilic Coatings: Hydrophilic coatings, which are known for their water-attracting properties, are becoming more prevalent in the medical device industry. These coatings are used on devices like catheters and guidewires to reduce friction and improve ease of insertion, ultimately enhancing patient comfort and minimizing tissue damage. The demand for hydrophilic coatings is expected to rise as procedural efficiency becomes a priority.

Biodegradable Coatings: Environmental concerns and the need for sustainable medical device solutions have led to the development of biodegradable coatings. These coatings gradually degrade within the body, eliminating the need for additional device removal surgeries. Biodegradable coatings are especially relevant in cardiovascular and orthopedic applications.

Key Segments Covered

By Type

Anti-Microbial Coatings for Medical Devices

Drug-Eluting Coatings for Medical Devices

Hydrophilic Coatings for Medical Devices

Other Types of Coatings for Medical Devices

By Application

Coatings for Cardiovascular Devices

Coatings for Orthopedic Devices

Coatings for Neurology Devices

Coatings for Gynecology Devices

Coatings for Other Applications

By Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East & Africa

The medical device coating market is witnessing rapid growth and innovation, driven by the need for improved device performance, biocompatibility, and durability. The adoption of advanced coatings, including nano-coatings, anti-microbial coatings, and hydrophilic coatings, is on the rise, as is the exploration of biodegradable solutions. Regulatory compliance, quality assurance, and international collaborations are crucial for the success of coating manufacturers in this highly regulated industry. As the healthcare industry evolves and emerging markets offer new opportunities, the medical device coating market is poised for further expansion and development. However, challenges such as adhesion and cost-effectiveness remain, prompting ongoing research and innovation in the field.

[healthcaremarketfmi]

Surgical Tourniquets Market Share, Top Operating Players, Recent Enhancements and Regional Analysis 2029

FMI’ analysis expects the surgical tourniquets market to grow at ~8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 381 million in 2019, up from ~US$ 355 million in 2018, according to the latest research from Future Market Insights (FMI).

Surgical tourniquets have long been reliable to establish a bloodless field of operation for surgeons while maintaining a high level of safety for patients. However, the risk of surgical-site infections as well as tourniquet-related injuries, particularly due to the application of high pressures and high pressure gradients to the patient, remains a potential threat to the market growth.

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

For More Information : https://www.futuremarketinsights.com/reports/surgical-tourniquets-market

Sales of Tourniquet Cuffs to Ramp up in 2019

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2018. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2018, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2019.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2018, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2018. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

Key Segment

By Product Type

Tourniquet Systems

Single Channel Systems

Dual Channel Systems

Tourniquet Cuffs

Inflatable Cuffs

Disposable Cuffs

Reusable Cuffs

Non-Inflatable Cuffs

Disposable Cuffs

Reusable Cuffs

[innovationtrends]

Syringe Market Trends, Business Growth and Major Driving Factors 2027

According to our new market research study on “Syringe Market to 2027 – Global Analysis and Forecast – by Syringe Type, Application, Usability and End Use,” the market is expected to reach US$ 26,859.34 million by 2027 from US$ 12,649.46 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00003521/  

Based on syringe type, the market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others. In 2019, the glass syringes segment held the largest share of the market. The segment is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to low mechanical tolerance, and smooth movement of the plunger. Furthermore, properties of glass, such as nonreactive nature and heat and chemical resistance, are contributing to the growth of this segment. Moreover, glass syringes are highly compatible with various drug filing devices and are easy to manufacture, which makes them the most preferred syringes in market. In March 2019, Gerresheimer AG launched metal free 1 ml long Luer lock Gx RTF glass syringes to deliver highly complex, protein-based bioengineered molecules.

In the last few years, the health care sector has witnessed SARS, H1N1 and other outbreaks. However, the severity of the coronavirus makes the situation more complex. Additionally, with no vaccine in market and only preventive measure to self-isolation is hitting the various industries including Syringe manufacturing in the region. The US and Canada have witnessed spike in cases in just few days, which has compelled the governments to shut down all the business in order to prevent the spread of the virus.. As of July 2020, in the US, more than 5.0 million confirmed corona cases were recorded and more than 160 thousands deaths were reported due to COVID 19 Pandemic. The syringe market is expected to be hit by the pandemic the most due to increasing number of cases and lockdown in most of the cities.

Becton, Dickinson and Company ; Baxter International Inc.; Terumo Corporation; Vita Needle Company; Cardinal Health Inc.; NIPRO; RETRACTABLE TECHNOLOGIES, INC.; B. Braun Medical Inc.; AIR-TITE PRODUCTS CO., INC.; and HENKE-SASS, WOLF Ltd., are among the leading companies operating in the syringes market.

Chronic diseases, such as diabetes, cardiovascular disease, and cancer, are among the primary causes of death in adults. Infectious diseases are also the top causes of death in children and adults. Chronic and infectious diseases need continuous diagnosis using various medical tests,which requires the use of syringes.

According to the World Health Organization estimations, around 16 billion injections are administered every year globally. It has been estimated that chronic diseases would account for almost three-quarters of all deaths worldwide, and that 75% of deaths due to stroke, 71% of deaths due to ischemic heart disease (IHD), and 70% of deaths due to diabetes would occur in developing countries by 2020. Many of these patients are advised regular intravenous administration of insulin, which increases the demand for syringes.

Infectious diseases are the secondtop cause of deaths worldwide and are among the top causes of death in children under age 5. For instance, the Centers for Disease Control and Prevention (CDC) stated that 1.7 million hospital-acquired infections (HAIs) occurred in 2017, and 99,000 associated deaths occur annually in American hospitals. It is estimated that nearly 32.0% of HAIs are urinary tract infections (UTIs), 22.0% are surgical site infections (SSIs), 15.0% are pneumonia, and 14.0% are bloodstream infections (BSIs).

Table of Contents                     

Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application: This section provides details about market size by product and application.

Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,

Continued....

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com

[healthcare-domain]

Hospital Acquired Infection Control Market Share, Size, Trends - [2021-2026]

Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years.  

The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19.

According to the new market research report, "Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers), COVID-19 Impact - Global Forecast to 2026", published by MarketsandMarkets™, the Hospital Acquired Infection Control Market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period.

Browse in-depth TOC on "Hospital Acquired Infection Control" 183 – Tables 48 – Figures 304 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204343466

The sterilization segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the increasing need to reduce surgical-site infections (SSIs), and the growing number of surgeries performed worldwide. Increasing initiatives and regulatory actions taken by governments in various countries to fortify hospitals with essential infection control standards to prevent the spread of HAIs are also expected to support market growth.

The hospitals & ICUs segment is expected to account for the largest share of the hospital acquired infection control market

Based on end user, the market has been segmented into hospitals & intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and other end users (dental clinics, trauma centers, and clinical laboratories).

Asia Pacific is expected to account for the highest CAGR for players operating in the hospital acquired infection control market

The Asia Pacific hospital infection control market is expected to grow at the highest CAGR from 2021 to 2026. Most of the growth in the market is expected from the emerging countries across the Asia Pacific. The rising number of surgical procedures conducted annually, favorable government regulations, the large patient population, and the rising incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=204343466

Various measures are being taken by companies as well as government bodies to drive market growth. For instance, the FDA has recommended that Sterigenics should reopen its ethylene oxide-based sterilization plant in the US. The plant had been shut due to harmful emissions, which were believed to be carcinogenic. In March 2020, the company received permission to reopen the plant for 21 days to sterilize PPE for healthcare workers to use during the COVID-19 pandemic. Such developments are anticipated to drive the growth of this market.

[blog-site-for-market-research]

Surgical Site Infection Control Market Size, Share & Trends Analysis Report

Market Synopsis

The Surgical Site Infection Control Market is estimated to grow at a 5.80% CAGR between 2022 and 2030, reaching USD 4969.21 million.

The rise in hospital-acquired infections is predicted to be a key factor driving the global surgical infection market 2020. The rising incidence of chronic illnesses like cancer, heart-related diseases, and others are likely to create a significant need for surgical infection control methods, which can augment the market during the forecast period. Furthermore, the increasing number of surgeries with the growing geriatric population is projected to increase the need for surgical infection controlling ways that can favor the market growth during the forecast period.

On the contrary, the lack of awareness of hospital infection can impede market growth in the coming period. However, the growing number of surgeries, along with  above-mentioned factors can counter the hampering factor and boost the market.

Market Segmentation

The segmental analysis of the global surgical infection control market is done by procedure, product, end-user, and type of infection.

The procedure-based segments of the global surgical infection control market are gastric bypass, caesarean section, cataract surgery, dental restoration, and others.

The product-based segments of the global surgical infection control market are disinfectants, manual reprocesses solution, surgical scrubs, surgical gloves, skin preparation solution, surgical drapes, medical nonwovens, and others. The disinfectants is further segmented into hand disinfectants and skin disinfectants.

The end user-based segments of the global surgical infection control market are hospitals and ambulatory surgical centres.

The type of infection based segments of the global surgical infection control market are deep incisional SSI organ or space SSI and superficial incisional SSI.

Regional Analysis

Based on the region, the global live cell imaging market is segmented into Europe, North America, Asia-Pacific, and the Rest of the World (RoW).

As per the analysis, the Americas is likely to dominate the global surgical infection control market owing to the significant investments in research and development programs. Furthermore, advanced healthcare infrastructure is likely to boost the regional market during the evaluation period. The growing incidence of chronic illness in the region is anticipated to be another notable factor in growing the regional market.

Europe is predicted to be the second-largest market during the forecast period owing to the growing awareness regarding hygiene and sanitation. In addition, the growing government initiatives to prevent infections is another significant cause fueling the regional market. However, the implementation of stringent rules and regulations can hamper market growth during the review period.

The APAC region is predicted to be the fastest-growing market during the forecast period due to lucrative opportunities. Emerging nations like India and China are anticipated to play a notable role due to the fast adoption of the latest technologies. Besides, the government of various nations present in the APAC region is likely to improve healthcare services, which can propel the regional market.

The MEA region is anticipated to acquire the least market share during the review period due to the presence of under-developed nations. However, the presence of untapped opportunities can fuel market growth in the coming period. Besides, Middle East countries' participation can prove to be profitable for the expansion of the regional market.

Key Players

Some of the renowned players of the global surgical site infection control market research are Becton Dickinson and Company, 3M, Belimed AG, bioMerieux SA, Johnson & Johnson, Getinge Group, Kimberly-Clark Corporation, Ansell Limited, Sotera Health, Steris Corporation, Pacon Manufacturing Corp, Lac-Mac Limited, American Polyfilm Inc., and others.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

[market-insider]

Disinfectant Spray Market Driven By COVID-19 and Growing At 8.2% Y.O.Y

The global disinfectant spray market size is expected to reach USD 18.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2022 to 2030. A rise in hospital-acquired infections such as central line-associated bloodstream infections, surgical site infections, catheter-associated urinary tract infections, hospital-acquired pneumonia, and ventilator-associated pneumonia is expected to have a positive impact on the market. Rising demand for advanced products to reduce the potential for virus contamination in non-healthcare settings, such as in the home, office, schools, gyms, publicly accessible buildings, faith-based community centres, markets, transportation and business settings or restaurants and importance to prevent infection from the COVID-19 virus across the globe is anticipated to drive the industry. The growing demand for a healthy and hygienic lifestyle is likely to fuel the overall demand. Sales of disinfectant sprays have risen drastically over the past few years, owing to the rising consumer awareness towards the benefits of disinfection and sanitization.

Gain deeper insights on the market and receive your free copy with TOC now @: https://www.grandviewresearch.com/industry-analysis/disinfectant-spray-market-report

EPA approved two products, Lysol Disinfectant Spray and Lysol Disinfectant Max Cover Mist, based on laboratory testing that shows the products are effective against SARS-CoV-2. According to USA Today, in March 2020, sales of disinfectant sprays increased more than 300% owing to the need to prevent COVID-19 infection. Major manufacturers such as 3M, Clorox, and Kimberly-Clark Corporation were not prepared for the unprecedented surge in the demand for disinfectants and sanitizers, resulting in a shortage in hospital facilities, clinics, and households. Thus, owing to this spike in demand, major manufacturers such as Clorox and Reckitt Benckiser Group are focusing on increasing their production capabilities, to suffice the rising demand from both B2B and B2C consumers. The conventional spray segment accounted for a larger share during the forecast period.

According to the U.S. Centers for Disease Control and Prevention (CDC), the overall incidence of surgical site infection (SSI) has been estimated to be 2.8%. To prevent such infections and diseases, conventional disinfectant sprays are used by all hospitals, medical facilities, nursing homes, and clinics. Thus, the rise in Hospital Acquired Infections (HAIs) across the globe is leading to a rise in demand for conventional disinfectant sprays for prevention. The B2B distribution channel segment held the larger segment in 2021 and is expected to maintain dominance over the forecast period. The rise in demand for infection prevention practices across hospitals and nursing homes is anticipated to fuel the demand for disinfectant sprays across the globe.

According to the COVID-19 Nursing Home Data by the Centers for Medicare and Medicaid Services (CMS), nursing homes across the U.S. reported nearly 1,800 COVID-19 deaths among residents and staff in August 2021 and a steady increase from the approximately 350 deaths reported in July 2021. This has led to an increase in precautionary measures such as the use of disinfectant sprays in nursing homes to prevent the spread of the deadly virus. The market is consolidated in nature with the presence of a large number of international players and few regional players. Reckitt Benckiser Group, Ecolab Inc., Procter and Gamble, 3M, Gojo Industries Inc., Whiteley Corporation, Kimberly- Clark, S.C. Johnson & Son Inc., Medline Industries, and Clorox Company are among the prominent players in the global market.

For Any Questions or Inquire please visit @: https://www.grandviewresearch.com/industry-analysis/disinfectant-spray-market-report/request/rs5

Grand View Research has segmented the global disinfectant spray market on the basis of type, distribution channel, and region

[techsciresearch]

United States Retail Clinics Market to Grow Due to Evolving Trends for Latest Healthcare Models until 2026 | TechSci Research

Evolving healthcare services are driving the growth of United States Retail Clinics Market, in the forecast period, 2022-2026.

According to TechSci Research report, “United States Retail Clinics Market By Ownership (Retail Store-Owned, Hospital-Owned, Investor-Owned, Others), By Location (Departmental Stores, Shopping Malls, Retail Stores, Others), By Services (Clinical Chemistry & Immunoassay, Point of Care Diagnostics, Immunization, Physiotherapy, Others), By Region, Competition Forecast & Opportunities, 2026”, the United States retail clinics market has shown promising growth in historical years until 2019 and is expected to continue its growth in upcoming forecast years till 2026. The United States retail clinics market owes its growth to the factors like rapidly evolving trends for latest healthcare models.

The surge in the demand for emergency healthcare facilities is further driving the growth of the United States retail clinic market in the upcoming five years. Moreover, the government initiatives to provide emergency services and immediate healthcare attention to the population in need is also substantiating the growth of the United States retail clinics market in the next five years.

Furthermore, the demand for retail clinics for performing rapid analysis tests for the diagnosis of the infection due to COVID-19 along with vaccination of the population and providing basic aid to the patients has increased and this factor is expected to substantiate the growth of the United States retail clinics market in the future five years.

Retail clinics are general healthcare centers for the immediate requirement of healthcare facilities. The trend for retail clinics is rapidly increasing in the United States. As of 2020, more than 3000 retail clinics have been already functional in the country. The facilities are highly focused on providing best possible urgent healthcare facilities that too at an affordable cost, convenient hours, non-appointment facility, convenient location, etc. These facilities are often staffed with nurse practitioners or physician assistants who offer treatment for common acute illnesses, screening tests, and vaccinations to patients aged 18 months or older.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "United States Retail Clinics Market"

https://www.techsciresearch.com/report/united-states-retail-clinics-market/7807.html

The United States retail clinics market is segmented on the basis of ownership, location, services, competitional landscape, and regional distribution. Based on location, the market is further segmented into departmental stores, shopping malls, retail stores, and others. Availability of retail clinics in places like departmental stores, shopping malls has contributed to the growth of the United States retail clinics market altogether as consumers are able to comfortably visit the facility even in the emergency conditions and get immediate medical attention. Departmental stores are anticipated to register highest revenue shares of the market on account of feasibility of the consumers in visiting the retail clinics. These kinds of stores do not require any prior appointments and thus drive the growth of the United States retail clinics market in the upcoming five years.

Based on services, the market is again segmented into clinical chemistry & immunoassay, point of care diagnostics, immunization, physiotherapy, and others. Clinical chemistry & immunoassay is an automated chemistry analyzer that measures enzymes, lipids, electrolytes, proteins and other such components in blood and urine. A sensitive measurement of antigen-antibody reaction is the process of immunoassay that is done to identify diseases like Ebola, COVID-19, etc. The rise in the number of coronavirus infected people has substantiated the growth of the clinical chemistry & immunoassay services in the upcoming five years.

Based on ownership, the market is further segmented into retail store-owned, hospital-owned, investor-owned, and others. Hospital-owned retail clinics are also expected to register significant growth in the next five years on the backbone of reliability on the clinics being owned by the renowned hospitals. Moreover, the services offered at the hospital-owned clinics are fully equipped and in case of extended services referring to the hospital and concerned experts is much convenient.

CVS Health Corporation, Walgreens Boots Alliance, Inc., Walmart Inc., Bellin Health Systems, Inc., Rite Aid Corporation, The Kroger Company, Aurora Health Care Inc., Next care Holdings, Inc., MedExpress Urgent Care, Concentra, Inc., among others dominate the United States retail clinics market. These market players hold the larger share of the market than the new market players. New market players may focus on the research and development to provide such services that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new introducing new services.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7807

Customers can also request for 10% free customization on this report.

“Added advantages of health insurance available for the healthcare services in the retail clinics in the United States is substantiating the growth of the market. The market analysis shows a promising growth in the future five years. Moreover, government initiatives to provide emergency facilities for the patients outside the hospital infrastructures is further aiding the growth of the market. New market players must focus on providing services in various states of the country, which will augment the growth of retail clinics market in the United States,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“United States Retail Clinics Market By Ownership (Retail Store-Owned, Hospital-Owned, Investor-Owned, Others), By Location (Departmental Stores, Shopping Malls, Retail Stores, Others), By Services (Clinical Chemistry & Immunoassay, Point of Care Diagnostics, Immunization, Physiotherapy, Others), By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of United States retail clinics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United States retail clinics market.

Browse Related Reports:

United States Biobanks Market By Type (Population Based Biobanks v/s Disease Oriented Biobanks) By Ownership (National/regional agency, Non-profit Organization, Universities, and Private Organization) By Product (Equipment & Consumables, Media, Software & Services) By Specimen Type (Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, Others) By Application (Therapeutic v/s Research) By End User (Academic Institutes, and Pharma & Biotech Companies, Others), By Region, Company Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/united-states-biobanks-market/7701.html

Global Hospital Acquired Infection Control Market By Product (Sterilizers, Disinfectors, Endoscope Re-processors, Others) By Application (Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others) By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/hospital-acquired-infection-control-market/7617.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[integraventures-21]

Growing need for Efficiently Planned Healthcare Building

Evolution of Hospitals:

Hospitals in earlier times served quite different purposes from those of today. They were founded to shelter older adults, the dying and to protect and treat the inhabitants of a community from contagious diseases. There is a paradigm shift in the role of Hospitals in the present-day scenario. The approach of Hospitals has been more broadened crossing the limits of Curative Health to Health care including Education, research, and training.

Technological advancement both in diagnostic as well as therapeutic areas, changing economic landscape, patient preferences are few other factors that have led to change in size, shape, and function of the Hospitals.

Role of Planning in modern Hospitals

Hospital Planning has evolved as an imperative tool for bringing in overall efficiencies in a Healthcare facility. Good Hospital design integrates functional requirements with the human needs and safety aspects of its varied users. Following are few attributes of a functionally planned Healthcare facility:

a. Need-based Development of Hospital: It is imperative to understand the healthcare needs of a place before establishing a Hospital. A detailed market research forms the basis on which the Hospital can be planned. The medical program is developed following the market assessment which entails the Specialty mix, Diagnostic facilities, Support services, and Bed mix in the Hospital. The Medical Program also gives an indication of the utilization trend of services and facilities in the proposed Healthcare facility thereby determining the level of infrastructure required.

b. Controlled Circulation: A hospital is a complex system of interrelated functions requiring constant movement of people and goods. Much of this circulation should be controlled thereby minimizing the crisscrossing of various traffic movements (staff, patients, attendants & visitors) across the facility. This requires optimal functional adjacencies of various departments within the Hospital. These adjacencies should be based on a detailed functional program that describes the hospital’s intended operations from the standpoint of patients, staff, and supplies.

c. Minimized cross-infection: Efficient Hospital Planning also ensures that the Hospitals are designed to incorporate infection control strategies to minimize the risk of infection transmission. This requires zoning of critical areas like Surgical suite, ICUs, Catheterization Laboratory, CSSD, etc. Zoning helps in ensuring an infection-free environment by separating the sterile areas from the general public access areas.

One of the other important requirements is to segregate critical areas like OT, ICU from general traffic and avoidance of air movement from areas like laboratories and infectious diseases wards towards critical areas. Provisioning of isolation rooms in ICUs & wards, dirty utility spaces, ante-rooms before entering critical areas, adequate washbasins are few other planning principles to keep in mind to ensure infection control.

d. Patient and Attendant friendly experience: Hospital patients are often fearful and confused and these feelings may impede recovery. If a Hospital is designed well, it can give the patient a much better healing experience. Every effort should be made to make the hospital stay as comfortable and stress-free as possible. The design of Hospitals should take patient’s psychological needs into account, such as ensuring adequate ventilation and natural light, inspiring views, relaxing gardens or courtyards, lots of art, pleasant color schemes, and “wayfinding”, to ease a patient’s hospital stay.

Nowadays, provision for accommodating attendants in adjunct to their ailing near ones is being promoted which is believed to improve the treatment outcome of the patients. This also reduces the attendant’s anxiety level and provides them with a comfortable hospital experience.

e. Improved staff satisfaction: Hospital is a 24 hours functional unit where staff needs to be dedicatedly working round the clock towards patient care. It is very imperative to consider the comfort level of the staff and provide them with the required functional spaces within the Hospital. Staff lounges, restrooms for resident doctors, counseling rooms, dining area, adequate number of toilets, change rooms, etc. are non-negotiable space considerations while planning a staff-friendly Hospital. Effective Hospital planning promotes staff efficiency by minimizing the distance of necessary travel between frequently used spaces

f. Environmentally responsible building: According to the World Health Organization, close to one-fourth of the diseases experienced by the world’s population can be attributed to environmental exposures. The healthcare industry is one of the largest consumers of energy. Hospital waste and energy consumption affect the health of the environment and, consequently, the health of each human being within the environment. While hospitals have the responsibility to treat the sick within their walls, they are also responsible to promote the health of clients, staff, and the environment. The duty of maintaining an environmentally friendly hospital is shared among numerous stakeholders within the organization. Following are some considerations one should make while planning a green Hospital:

Protect trees and topsoil during site work.

Prioritize parks, greenways, and bikeways throughout the new hospital area.

Consider (re)use of existing buildings, including structure, shell, etc. (in case of renovation or up-gradation projects)

Orient building to take advantage of solar energy for heating and daylighting and to encourage natural ventilation and passive cooling

Consider collecting stormwater runoff for other purposes (irrigation) on the site.

Ensure adequate space for storage of hazardous waste (e.g., biomedical, chemical, radioactive, etc.)

Use high-performance windows (double-glazed, argon, etc.)

Healthy environments can result in better patient outcomes, healthier staff and allow the facility to promote itself as a positive, healthy contributor to its community.

g. Future proofing through Modular Construction: Since medical needs and modes of treatment will continue to change, hospitals should follow modular concepts of space planning and layout. The use of modular construction is directly influenced by the client’s requirements for speed of construction, the addition of new departments, least disturbance to existing facilities, quality, and added benefits of economy of scale as well as single point procurement.

Planning has to be open-ended, with well-planned directions for future expansion; for instance positioning “soft spaces” such as administrative departments, adjacent to “hard spaces” such as clinical laboratories.

Conclusion

Appreciation of Hospital Planning elements has started taking precedence in modern-day Hospitals. The country is in a state of Healthcare transition where both Government and Private players are intensively investing in the sector. There is also an immediate need to upgrade old public sector Hospitals which have been growing sporadically over the years. It has created greater inefficiencies in the healthcare facilities thereby compromising patient care aspects. Here, Hospital Consultants have a big role to play in developing efficient and responsible healthcare facilities. Hospital Planners/Administrators need to work in sync with Architects with inputs from the promoters to establish facilities that are in line with the promoters’ vision, local needs, and comfort & security concerns of patients, staff, and other stakeholders.

Author: Dr. Jyoti Rama Das (Co-Founder & Managing Partner — Integra Ventures)

[omkarpatel]

Dental Dam Market is Estimated to Witness High Growth Owing to Increasing Dental Procedures

Dental dams are thin sheets of latex used by dental professionals during various dental procedures to isolate the operative site and protect the patient from possible dangers. They are used during root canals, oral surgery, and other procedures to prevent debris, fluids, or dental materials from entering the throat or respiratory tract.

Market Dynamics:

The growth of the dental dam market is mainly attributed to the increasing number of dental procedures worldwide along with rising incidence of dental diseases. According to the World Health Organization (WHO), oral diseases affect over 3.9 billion people globally. Additionally, increasing awareness about oral health and availability of advanced dental treatments are further supporting the growth of the market. Furthermore, technological advancements in dental dams allowing incorporation of antimicrobial properties are also promoting their adoption. However, higher prices and availability of alternative isolation methods may hinder market growth over the forecast period.

Rising Dental Treatments and Procedures is Driving the Dental Dam Market

As awareness about oral health is increasing worldwide, various dental treatments and procedures such as dental fillings, root canals, crowns, etc. are also rising. Proper sterile conditions are required during these treatments which can be effectively maintained using dental dams. They help isolate the operative site and protect the patient's mouth from debris and infectious agents. With more people opting for various restorative and cosmetic dental procedures, the demand for dental dams from hospitals and clinics is significantly growing.

Increasing Prevalence of Periodontal Diseases is Boosting the Dental Dam Market

Gum disease or periodontal disease is a widespread problem affecting people across all age groups. Conditions like gingivitis and periodontitis require thorough cleaning of teeth and gum areas during their treatment. Dental dams aid dentists in maintaining adequate isolation and visibility of the operative field during scaling and root planning procedures. As prevalence of periodontal diseases rises worldwide largely due to changing lifestyles and food habits, consumption of dental dams is increasing accordingly to manage infection control effectively.

Lack of Proper Sterilization Standards in Dental Facilities is Restraining the Dental Dam Market

Many dental clinics and practices in developing regions still lack adequate sterilization policies and protocols. This makes cross-contamination between patients very likely. Although cost-effective, using reusable dental dams multiple times without following proper disinfection guidelines can spread infectious diseases. Such improper practices are hindering wider adoption of dental dams. Stringent regulations and enforcement of sterilization standards across all healthcare setups need to be implemented to overcome this challenge.

Growing Demand for Cosmetic Dentistry Offers Opportunities

With rising incomes and focus on appearance, cosmetic dentistry has become highly popular globally in recent years. Procedures like teeth whitening, veneers, gum lifts require isolation of specific areas inside the oral cavity for precision work. This presents lucrative opportunities for single-use dental dams optimized for such esthetic treatments. Companies can manufacture dental dams in varied sizes, shapes and materials suitable for different cosmetic procedures to grab a larger share of this expanding market segment.

Increasing Digitalization is a Major Trend in the Dental Dam Market

Advanced digital technology is gradually being incorporated in the dental industry. Many dentists have started using intraoral cameras, 3D scans and CAD/CAM systems for restorative and surgical procedures. Dental dam manufacturers are developing innovative digital solutions as well, like e-commerce platforms for purchases, and AR/VR guided templates for precise dam placement customized to each individual patient's oral anatomy. Growing digitalization offers immense potential to streamline dental dam usage workflows and help boost their adoption rates going forward.

[sapanas]

Surgical Site Infection Control Market 2019 Global Industry Analysis, Development, Size, Share, Opportunities, Future Growth and Business Prospects By Forecast To 2023

Market Research Future published a half-cooked research report on the Surgical Site Infection Control Market Research Report - Global Forecast till 2023.

Surgical Site Infection Control Market Insight

The surgical site infection control market is growing pervasively over the past few years. Rising prevalence of hospital-acquired infections (HAI) and the most common types of HAI, such as surgical site infections and bloodstream infection (BSI) are expected to drive the market growth predominantly.

Surgical site infections (SSI) are critical and sometimes are dangerous, too, which can cost hugely, resulting in higher mortality rates each year. In such a scenario, surgical site infection control becomes crucial. As a result, the surgical site infection control market is witnessing a rising demand. According to Market Research Future (MRFR), the global surgical site infection control market can impressively grow and attain a CAGR of 6.7% during the forecast period of 2018 to 2023.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7830

Wide-spreading awareness of this kind of infection and the availability of novel medications & treatment procedures can propel the growth of the market. Also, improving economic conditions worldwide fuel market growth, enabling access to improved healthcare.

Moreover, technological advances in medical science backed by the substantial investments made in the R&D activities foster market growth excellently.

Conversely, unmet clinical needs alongside the incidents of drug resistance, complications, and side effects occurring during treatments are some of the factors expected to impede the market growth during the forecast period. Nevertheless, increasing government support for research & development would support the growth of the surgical site infection control market.

Surgical Site Infection Control Market - Segments

The market report has five dynamics to widen the scope of understanding,

By Product: Manual Reprocessors Solution, Disinfectants (Hand Disinfectants, Skin Disinfectants, Surgical Scrubs, Surgical Drapes, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, others), and others.

By Procedure: Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass, and others.

By Type of Infection: Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI, and others.

By End-user: Ambulatory Surgical Centers, Hospitals, and others.

By Regions: North America, Europe, APAC, and the Rest-of-the-World (RoW).

Global Surgical Site Infection Control Market - Regional analysis

North America dominates the global surgical site infection control market. The presence of well-established healthcare sectors in the region drives the growth of the regional market. Rising number of surgeries and increasing awareness regarding the healthcare management can foster the growth of the market. Moreover, comprehensive insurance coverage and the expansion of the private healthcare sector impact the market growth positively, improving overall healthcare infrastructure.

The US and Canada account for the largest share in the surgical site infection control market in the region due to the rising patient population and increasing prevalence of SSI. Furthermore, high per capita health care expenditures and growing investments in R&D to develop new techniques to cure surgical site infection control act as major growth drivers.

Europe stands second in the global surgical site infection control market. Increasing awareness of hygiene & sanitation, government support for high degree infection prevention programs, and formulation of various initiatives by NGO & Government to increase the awareness drive the regional market growth. The emergence of technologically advanced medical products, intense healthcare penetration, the availability of advanced treatment facilities, and skilled medical professionals can act as major thrust providers for the market.

The Asia Pacific surgical site infection control market is rising rapidly. The vast population and the availability of low-cost medications & procedures to treat the surgical site infection control foster regional market growth. Furthermore, the burgeoning healthcare sector in the region, along with the high unmet needs, would provide impetus to the regional market growth over the forecast period.

The Asia Pacific demonstrates a vast market potential with its warm weather favorable for the growth of various kinds of infections. Consequently, governments across the countries around the region have taken various efforts to improve healthcare services and provide better infrastructure. India and China are the leading markets in the region, followed by South Korea.

Global Surgical Site Infection Control Market - Competitive Analysis

Highly competitive, the surgical site infection control market appears to be fragmented, characterized by the presence of several well-established players. To gain a significant market share, players incorporate strategic initiatives such as mergers & acquisitions, collaborations, expansion, and new therapeutics & technology launch.

They invest heavily in R&D and clinical trials to develop effective drugs, focusing on areas with a high unmet medical need, these companies assess areas that require further innovation over the progress that has been made. Substantial investments made by the top players to develop novel therapeutics for these infections, help these players to hold significant market share.

Major Players:

Players leading the global surgical site infection control market, include 3M, Becton Dickinson and Company, Belimed AG, bioMerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark Corporation, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp, and American Polyfilm Inc., among others.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/surgical-site-infection-control-market-7830

Industry/Innovations/Related News:

October 11, 2019 ---- 3M, an American multinational conglomerate operating in the fields of industry, worker safety, health care, and consumer goods, announced the completion of Acelity L.P. Inc. (the US), a medical device company and its KCI subsidiaries worldwide. Acelity is one of the leading medical technology company globally.

The acquisition worth approximately USD 6.7 BN would further accelerate 3M’s role as a leader in treating advanced wound care, which is a significant and growing market segment. Recently, on May 16, 2019, had announced receiving the FDA approval for its PREVENA negative pressure incision management system indicated to help with reducing superficial surgical site infections in those at high risk of post-op infections.

October 22, 2019 ---- Becton, Dickinson and Company India, a leading medical technology company conducted a program 'Heal-o-nomics' conceptualized to apprehend the challenges in preventing hospital-acquired infections (HAIs) to achieve better health outcomes at optimized cost, Including the most common types such as surgical site infections, and bloodstream infection (BSI). Presented studies include the epidemiology and prevention of BSI and the evaluation rates device-associated infections across Indian hospitals. The rising number of HAI in India has led experts to gather and discuss the ways to prevent them.

[ashukalbande21-blog]

Hospital-Acquired Infections Market 2019 Global Trend, Segmentation and Opportunities Forecast To 2022

Market Research Future has added a report titled “Hospital-Acquired Infections Market Research Report- Global Forecast to 2022” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Market Scenario:

The Global Hospital Acquired Infections Market was $23.7 billion in 2016 and is expected to reach around $36.16 billion by the end of the forecast period growing at a CAGR of 7.3%.

A hospital acquired infection (HAI) or nosocomial infection or health care associated infection (HAI or HCAI), is an infection that is acquired in a health care facility. The infection acquired in health care facility by a patient must be other than the one for which the patient was admitted and includes infections acquired in the hospital however effects and symptoms appear after discharge. The HAI also includes occupational infection among staff of the hospital.

The infection can originate from outside environment, another infected patient, or from staff that may be infected; in some cases, the source of the infection cannot be determined. There are cases where microorganism originates from the patient's own skin micro biota, becoming opportunistic after surgery or other procedures that compromise the protective skin barrier. WHO estimates that 8.7% of hospital patients had nosocomial infections affecting over 1.4 million people worldwide.

Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/2576

The market’s driving factors are nature and virulence of the microbial agent, patient susceptibility such as immunity, presence of other diseases, environmental factors such as infected materials and bacterial load in hospitals, crowding, temperature and humidity etc., bacterial resistance to drugs, the age of patient., high prevalence of HAI, lack of awareness, poor training and infection control practices, poor hospital infrastructure and regulation, low expenditure on healthcare, rise of chronic diseases with prolonged stay in hospitals etc.

The market restraints are growth of microbial resistance, spurious and counterfeit products, off label use of antiseptics and drugs, rise of disposables, increasing use of quality construction material such as ceramics and glass in buildings, huge fragmentation of market & number of players, loss of patents & great penetration of generics etc. The technology advancement in the form of gas plasma sterilization technology will drive the future global HAI market.

Key Players for Global Hospital-Acquired Infections Market:

Advanced Sterilization Products, 3M Company, Becton Dickinson and company, STERIS Corporation, Getinge AB, Cantel Medical Corp., Belimed AG, and others.

Segments:

Global Hospital Acquired Infections Market has been segmented on the basis of pathogen types which comprises of viral, bacterial and fungal. On the basis of method of treatment the market is segmented into sterilization, chemical, radiation and on the basis of infection type market is segmented into urinary tract infections, blood stream infections, surgical site infections, gastrointestinal infections, and respiratory infections.

Regional Analysis of Global Hospital-Acquired Infections Market:

The prevalence of HAI is greater in Mediterranean and Southeast Asia. Nations are close to the extreme north of the Northern Hemisphere have the least prevalence of HAI such as Norway. Globally America is the largest market for hospital acquired infections market which is expected to reach around $12 billion by the end of the forecast period 2022.The growth of this market has started since 2016 thus, growth period of this market can be stated as 2016 to 2022. Europe is the second largest market for hospital acquired infections. Asia Pacific region is expected to be fastest growing region in hospital acquired infections market.

Browse Full Reports @ https://www.marketresearchfuture.com/reports/hospital-acquired-infections-market-2576